The Burden of and Risk Factors for Trachoma in Selected Districts of Zimbabwe: Results of 16 Population-Based Prevalence Surveys. by Phiri, Isaac et al.
LSHTM Research Online
Phiri, I; Manangazira, P; Macleod, CK; Mduluza, T; Dhobbie, T; Chaora, SG; Chigwena, C; Katiyo,
J; Willis, R; Bakhtiari, A; +6 more... Bare, P; Courtright, P; Macheka, B; Midzi, N; Solomon, AW;
Global Trachoma Mapping Project; (2017) The Burden of and Risk Factors for Trachoma in Selected
Districts of Zimbabwe: Results of 16 Population-Based Prevalence Surveys. Ophthalmic epidemiology.
pp. 1-11. ISSN 0928-6586 DOI: https://doi.org/10.1080/09286586.2017.1298823
Downloaded from: http://researchonline.lshtm.ac.uk/3929270/
DOI: https://doi.org/10.1080/09286586.2017.1298823
Usage Guidelines:
Please refer to usage guidelines at https://researchonline.lshtm.ac.uk/policies.html or alternatively
contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
https://researchonline.lshtm.ac.uk
ORIGINAL ARTICLE
The Burden of and Risk Factors for Trachoma in Selected Districts of Zimbabwe:
Results of 16 Population-Based Prevalence Surveys
Isaac Phiria, Portia Manangaziraa, Colin K. Macleodb,c, Takafira Mduluzad,e, Tinashe Dhobbiea,
Shorai Grace Chaoraf, Chriswell Chigwenaa, Joshua Katiyoa, Rebecca Willisg, Ana Bakhtiarig, Peter Bareh,
Paul Courtrighti, Boniface Machekaj, Nicholas Midzik, and Anthony W. Solomonb,l, for the Global Trachoma
Mapping Project*
aDepartment of Epidemiology and Disease Control, Ministry of Health and Child Care, Harare, Zimbabwe; bClinical Research Department,
London School of Hygiene & Tropical Medicine, London, UK; cSightsavers, Haywards Heath, UK; dDepartment of Biochemistry, Faculty of
Sciences, University of Zimbabwe, Mt Pleasant, Harare, Zimbabwe; eSchool of Laboratory Medicine and Medical Sciences, College of Health
Sciences, University of KwaZulu-Natal, Durban, South Africa; fNational Statistical Agency, Harare, Zimbabwe; gTask Force for Global Health,
Atlanta, GA, USA; hSightsavers, Harare, Zimbabwe; iKCCO International, Division of Ophthalmology, University of Cape Town, South Africa;
jDepartment of Ophthalmology, Parirenyatwa Group of Hospitals, Harare, Zimbabwe; kDepartment of Medical Microbiology, College of
Health Sciences, University of Zimbabwe, Harare, Zimbabwe; lDepartment of Control of Neglected Tropical Diseases, World Health
Organization, Geneva, Switzerland
ABSTRACT
Background: Trachoma, a leading cause of blindness, is targeted for global elimination as a public health
problem by 2020. In order to contribute to this goal, countries should demonstrate reduction of disease
prevalence below specified thresholds, after implementation of the SAFE strategy in areas with defined
endemicity. Zimbabwe had not yet generated data on trachoma endemicity and no specific interven-
tions against trachoma have yet been implemented.
Methods: Two trachoma mapping phases were successively implemented in Zimbabwe, with eight
districts included in each phase, in September 2014 and October 2015. The methodology of the Global
Trachoma Mapping Project was used.
Results: Our teams examined 53,211 people for trachoma in 385 sampled clusters. Of 18,196 children
aged 1–9 years examined, 1526 (8.4%) had trachomatous inflammation–follicular (TF). Trichiasis was
observed in 299 (1.0%) of 29,519 people aged ≥15 years. Of the 16 districts surveyed, 11 (69%) had TF
prevalences ≥10% in 1–9-year-olds, indicative of active trachoma being a significant public health
problem, requiring implementation of the A, F and E components of the SAFE strategy for at least 3
years. The total estimated trichiasis backlog across the 16 districts was 5506 people. The highest
estimated trichiasis burdens were in Binga district (1211 people) and Gokwe North (854 people).
Conclusion: Implementation of the SAFE strategy is needed in parts of Zimbabwe. In addition,
Zimbabwe needs to conduct more baseline trachoma mapping in districts adjacent to those identified
here as having a public health problem from the disease.
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Introduction
Trachoma is an infectious eye disease caused by the bacter-
ium Chlamydia trachomatis. Classed by the World Health
Organization (WHO) as a neglected tropical disease, tra-
choma is the world’s leading infectious cause of blindness.
It is thought to be a public health problem in 42 countries,
mostly in Africa and the Middle East.1 Early signs are most
commonly found in young children, with female adults
(who generally spend more time with children) having
the highest burden of advanced, blinding disease.2
Globally, 200 million are thought to be at risk.1
Infection is thought to be transmitted from eye to
eye by flies, fingers and fomites bearing ocular or nasal
secretions of infected individuals.3–6 Repeated conjunc-
tival infection causes chronic inflammation, eventually
causing scarring and (in some people) in-turning of the
eyelids so that the eyelashes touch the eye, a condition
called trichiasis.7,8 Trachomatous conjunctival scarring
also reduces tear secretion, predisposing the cornea to
ulceration, which may lead to its opacification: the
ultimate mechanism through which trachoma produces
blindness.8
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Trachoma is normally found in isolated, resource-
limited settings where water scarcity and low levels of
sanitation and healthcare access are commonplace—
conditions thought to facilitate C. trachomatis
transmission.3,5,9 In addition to direct blinding effects
on individuals, trachoma profoundly affects the econo-
mies of endemic communities, where it is estimated
that $2.9 to $8 billion in productivity is lost every
year from the disease.10,11 It is against this background
that trachoma has been targeted by WHO for elimina-
tion as a public health problem by the year 2020,12
defined as an estimated prevalence of the clinical sign
trachomatous inflammation–follicular (TF) of <5% in
children aged 1–9 years, and an estimated prevalence of
the clinical sign trachomatous trichiasis in those aged
15 years and greater of <0.2%.
Zimbabwe is a landlocked country in Southern Africa
bordering Zambia, Mozambique, Botswana and South
Africa. The estimated total population is 13,061,239, with
8,771,520 people (67.2%) living in rural areas. The country’s
major ethnic groups are the Shona, Ndebele, Karanga,
Ndau, Zezuru, and Manyika. Trachoma is known in
Zimbabwe’s rural health clinics, but reporting on it has
hitherto only been included under “general eye conditions”
in national health information systems, with no formal
estimates of prevalence or incidence of clinical
presentation.13 To date, therefore, few data exist to guide
stakeholders to understand the burden of trachoma in the
country, or to plan interventions where required.
There are a few specific reports on trachoma in
Zimbabwe. Published in 1970, a survey in the area
North-East of Harare found that 30% of the 0–5 years
age group, and 23% of the 6–15 years age group, had a
follicular conjunctivitis consistent with active
trachoma.14 A cataract surgery outreach to Gokwe
South district in 2015 found so many cases of trichiasis
that more surgeries were carried out for trichiasis than
for cataract (unpublished data, Dr B. Macheka). It is
also notable that Zimbabwe borders trachoma-endemic
districts in Zambia to the North,15 and Mozambique to
the North-East.16
As is common in many developing countries, in
Zimbabwe’s rural districts, factors normally associated
with trachoma are present—extreme poverty is com-
monplace, water access is limited, and sanitation provi-
sions are minimal. However, the status of trachoma
endemicity in large areas of the country is unclear.
Definitive district-level prevalence data are needed in
order to guide the Ministry of Health and their partners
to plan for national trachoma elimination as a public
health problem.
We conducted 16 district-level population-based tra-
choma prevalence surveys in two phases, in 2014 and
2015, with the aims of estimating the prevalence of TF in
children aged 1–9 years, and the prevalence of trichiasis in
those aged 15 years and greater, as well as obtaining data on
the water, sanitation, and hygiene (WASH) variables most
commonly associated with trachoma.We report the results
of those surveys in this paper.
Methods
Study design and study sites
With few existing data, we were not confident of where
formal surveys were justified, so a phased approach was
used. In the first phase, in September 2014, eight popula-
tion-based cross sectional prevalence surveys were carried
out, with one district selected from each of the eight pro-
vinces of Zimbabwe (Manicaland, Mashonaland East,
Mashonaland Central, Mashonaland West, Midlands,
Masvingo, Matabeleland South, Matabeleland North).
Districts were selected based on suspected trachoma ende-
micity from existing government reports. In the second
phase, districts adjacent to phase 1 districts in which the
TF prevalence in children aged 1–9 years was ≥5% were
considered for further surveys; these were undertaken in
October 2015.
The overall survey protocol was implemented according
to the published methodology for the Global Trachoma
Mapping Project (GTMP),17 with Zimbabwe-specific adap-
tations related to selection of populations to survey, as
outlined in the previous paragraph, and procedures for
obtaining consent and assent (see below). Surveys were
carried out with existing administrative districts used as
evaluation units. Table 1 identifies the districts selected for
phases 1 and 2.
Sample size estimation and sampling procedures
The sample size calculation used the single population
proportion for precision formula. To have 95% confidence
(α = 5%) of estimating a true TF prevalence in 1–9-year-
olds of 10% with an absolute precision of 3%, assuming a
cluster survey design effect of 2.65 and inflation by a factor
of 1.2 to account for non-response, each survey needed to
include sufficient households to expect 1222 children to be
resident.17 This sample size was alsomore than adequate to
estimate a true TF prevalence in 1–9-year-olds of 4% with
an absolute precision of 2%.18 In rural Zimbabwe, themean
household size is 4.4 people and approximately 26% of the
population is aged 1–9 years,19 providing an average of 1.14
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1–9 year-olds per household. Therefore, 1222/1.14 = 1073
households were required per district.
Two-stage cluster sampling was used for each sur-
vey, with enumeration areas, (the lowest administrative
units used for generating census data in Zimbabwe)
sampled in the first stage; a sample of 45 households
from each enumeration area was selected in the second
stage. Selection of 24 enumeration areas per district was
performed using a probability proportional to size,
systematic sampling methodology, using enumeration
area population sizes obtained from the Zimbabwe
National Statistics Agency.19 Substitution of selected
enumeration areas was only permitted with approval
of the study coordinator, and only when field teams
found that the village no longer existed, or was
unreachable by vehicle, motorcycle, boat or foot. In
those cases, teams visited the geographically next-near-
est enumeration area. An additional cluster was selected
in Mutoko district to ensure an adequate sample size
was obtained.
Household selection was performed on the day of
the survey, at village level. As household listings were
not available, compact segment sampling was used. The
survey team liaised with the village chief who provided
a map in which segments, each comprising approxi-
mately 45 households, were demarcated. Teams then
randomly selected one segment by drawing straws, and
included all households in the selected segment.
At sampled households, graders examined consent-
ing individuals for signs of trachoma using the WHO
simplified grading system,7 2.5× magnifying loupes,
and sunlight illumination. All data were recorded elec-
tronically in a custom-made smartphone application
(LINKS, Task Force for Global Health, US), as pre-
viously described.17
Survey teams
Teams were composed of one grader, one recorder, one
village chief/guide and a driver. Graders were
Ophthalmic Nurses who had been trained and certified
by the GTMP. Recorders were GTMP-certified
Provincial Health Information Officers. Eight survey
teams were trained, using version 3 of the standardized
GTMP training system,20 in Kwekwe, Zimbabwe.
At the central level, coordination and supervision
were organized by the National NTD Task Force
Committee through the Epidemiology and Disease
Control Department, Ministry of Health and Child
Care. Four field supervisors (members of the
Zimbabwe Neglected Tropical Diseases steering com-
mittee) ensured quality data collection.
Ethics statement
The survey protocol was approved by the National
Ethical Regulatory Board (Medical Research Council
of Zimbabwe; reference MRCZ/A/1893) and the
Ethics Committee of the London School of Hygiene &
Tropical Medicine (reference numbers 6319 and 8355).
Participation in the survey was voluntary. Survey team
members explained to village chiefs and members of
the selected households the purpose of the survey and
what their participation involved. Participants were
assured of confidentiality and were made aware that
decisions on whether or not to take part would in no
way affect future service provision. No adverse effects
were anticipated from participating. For all individuals
with trichiasis or active trachoma, referral or antibiotic
treatment, respectively, was provided. Written,
informed consent was obtained from all adults aged
≥18 years, and from parents, caregivers, or heads of
households for those under 18 years of age. Assent was
obtained from individuals aged 15–17 years after par-
ental informed consent had been granted.
WASH and climate data
WASH variable data were collected by data recorders
using direct observation and standardized interview
questions with the household head. Variables related
to water access and source type for both drinking and
washing, and sanitation types, used WHO/UNICEF
Joint Monitoring Programme definitions for improved
Table 1. Districts selected for the first two phases of trachoma mapping in Zimbabwe, 2014–2015.
Province
Districts
Phase 1 Phase 2
Manicaland Chipinge
Mashonaland East Mudzi Mutoko, Uzumba Maramba Pfungwe
Mashonaland Central Mbire Rushinga, Centinary
Mashonaland West Kariba Hurungwe,
Midlands Gokwe North Gokwe South
Masvingo Chivi
Matabeleland South Magwe
Matabeleland North Binga Lupane, Hwange
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and unimproved water and sanitation sources.21,22 We
sought climatic data possibly related to C. trachomatis
infection transmission,23 based on knowledge of the
epidemiology of trachoma in comparable environ-
ments. Data derived from local meteorological stations
were obtained from WorldClim/BioClim (worldclim.
org),24 at a resolution of 2.5 arc-minutes (~5km):
mean annual temperature, mean annual precipitation,
and maximum temperature in the hottest month.
Altitude was recorded by collecting Global Positioning
System coordinates at each household at the time of
survey.
Data management
Descriptive data were produced using Excel 2010.
Adjusted prevalence and confidence intervals were
calculated using R 3.0.2 (The R Foundation for
Statistical Computing, 2013). In order to estimate
the population-level outcomes required for existing
WHO guidelines, both TF and TT proportions were
adjusted at cluster-level. This was done to partially
account for the fact that conducting surveys during
daylight hours results in a proportion of school-
attending children and working adults (often males)
remaining unexamined. The TF prevalence in chil-
dren aged 1–9 years was adjusted for age in 1-year
age-bands using the latest available census data.19
Trichiasis prevalence estimates in those aged 15 or
more years were adjusted for age and sex in 5-year
age-bands. For each district, the overall outcome pre-
valence was estimated by taking the arithmetic mean
of adjusted cluster-level proportion estimates from
that district. Trichiasis prevalence for the whole
population was estimated by halving the 15+ years
trichiasis prevalence.25 Confidence intervals were gen-
erated using a bootstrapping approach, randomly
resampling with replacement from the set of all
adjusted cluster-level outcome proportions for each
district, and calculating the arithmetic mean of these
proportions from the set of resampled clusters. A 95%
confidence interval was estimated by taking the 2.5th
and 97.5th centiles of these results, obtained over
10,000 replicates. Bootstrap estimates assumed nor-
mally distributed proportions, which held in all but
the very lowest trichiasis prevalence estimates. The
confidence intervals for zero counts were estimated
by an exact binomial confidence interval.
Raster point values for climatic variables were
extracted using ArcGIS 10.3 (Spatial Analyst). Risk
factor analysis was performed using Stata 10.2 (Stata
Corp, TX, USA). A multi-level hierarchical model was
used to account for clustering at enumeration area and
household level. Co-linearity of variables was not an
absolute exclusion criterion, but was assessed using
Mantel-Haenszel tests of association. A stepwise inclu-
sion approach was used for the multivariable model,
with variables considered for inclusion if the univari-
able association was significant at the p < 0.05 level
(Wald’s test). Variables were retained in the model if
statistical significance was found at the p < 0.05 level
(Likelihood ratio test).
Estimation of design effect
The increase in variance of the estimated proportion of
children with TF in each district, due to the clustered
design of the survey, is given by the design effect (DE).
The DE for each district was estimated by dividing the
bootstrapped variance estimate of the cluster-level TF
proportions by the equivalent simple random sampling
(SRS) variance estimate for the same sample size.
Assuming SRS, if p is the proportion of children
examined with TF in a given district, and n is the
total number of children examined in the same district,
then the SRS variance in this proportion is given by p(1
−p)/n, the formula for the variance of a Normally dis-
tributed sample proportion.
Results
Trachoma survey phases 1 and 2 were conducted in
September 2014 and October 2015 respectively. The dis-
tricts targeted in phase 2 were based on their proximity to
those phase 1 districts in which a TF prevalence of greater
than 5% in children had been observed. Table 2 shows
data on numbers of people registered and examined for
each district. A total of 17,299 households were visited,
from which 55,992 people were registered. Of these,
53,211 (95%) were examined. Of those examined, 23,360
(43.9%) were males.
Results of examination by district are shown in Table 3.
Of 18,196 children aged 1–9 years examined, 1526 (8.4%)
had TF, whereas TF was observed in only 225 (4.1%) of
5496 children aged 10–14 years. No children aged 1–9
years, and only three children aged 10–14 years, had
trichiasis. Of the 29,519 individuals aged 15 years and
greater who were examined, 299 cases of trichiasis were
identified (1.0%). Overall, 36 cases of trichiasis were in
those aged 15–39 years, and 263 cases were in those aged
40 years or greater.
Figure 1 and Table 4 show the adjusted prevalence of
TF among 1–9-year-olds, by district. Table 5 presents
recommendations for implementation of SAFE, based
on adjusted prevalence of TF and trichiasis in each
surveyed district. Five districts had TF prevalence
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<5%, the elimination threshold for TF. In these dis-
tricts, according to WHO guidelines, the A, F and E
components of SAFE are not necessary for the purposes
of trachoma’s elimination as a public health problem. A
total of eight districts had a TF prevalence between 5
and 9.9%, and a further three (Centenary, Gokwe South
and Lupane) had a TF prevalence of 10–29.9%; accord-
ing to WHO guidelines, these 11 districts require
implementation of the A, F and E components of
SAFE before resurvey.
Figure 2 and Table 6 show the adjusted district-level
prevalence of trichiasis in the population aged ≥15 years,
and estimated surgery backlogs. Of 16 districts, 10 (62.5%)
had adjusted trichiasis prevalence ≥0.2%. Overall the esti-
mated trichiasis backlog was 5506 individuals. This figure
was highest in Binga district, where an estimated 1297
people will need to be counselled for possible surgery.
Estimation of design effect
Themedian number of children examined per cluster was
45 (Interquartile range [IQR]: 37–56); TF cases per cluster
was three (IQR: 1–5); proportion of children with TF per
cluster was 0.058 (IQR: 0.025–0.120), and the median
number of children examined per district was 1142
(IQR: 1011–1267.25). The median bootstrap variance of
the primary sampling unit (cluster-level) TF proportions
was 11.0 × 10−5 (IQR: 4.1–34.5), and the median DE over
all 16 districts with a median of 45 children examined per
cluster was 2.20 (IQR: 1.27–3.47).
Table 2. Sampling by district, Global Trachoma Mapping Project, Zimbabwe, 2014–2015.
Province District Households (n)
Individuals
Registered (n) Examined (n, %) Absent (n, %) Refused (n, %) Other (n, %)
Manicaland Chipinge 1073 3827 3735 (97.6) 53 (1.4) 39 (1)
Mashonaland Central Mbire 1079 2800 2749 (98.2) 33 (1.2) 18 (0.6)
Rushinga 1078 2817 2803 (99.5) 11 (0.4) 3 (0.1)
Centenary 1076 2708 2706 (99.9) 0 (0) 2 (0.1)
Mashonaland East Mudzi 1086 3590 3326 (92.6) 253 (7) 11 (0.3)
Mutoko 1126 3416 3377 (98.9) 37 (1.1) 2 (0.1)
Uzumba Maramba Pfungwe 1074 3351 3255 (97.1) 29 (0.9) 67 (2)
Mashonaland West Kariba 1063 3630 3285 (90.5) 338 (9.3) 7 (0.2)
Hurungwe 1079 3504 3307 (94.4) 193 (5.5) 4 (0.1)
Masvingo Chivi 1063 3074 2592 (84.3) 473 (15.4) 3 (0.1) 6a(0.2)
Matabeleland North Binga 1072 3376 2928 (86.7) 383 (11.3) 65 (1.9)
Lupane 1096 3882 3826 (98.6) 37 (1) 15 (0.4) 4b(0.1)
Matabeleland South Mangwe 1097 3664 3602 (98.3) 58 (1.6) 4 (0.1)
Hwange 1079 4215 4155 (98.6) 41 (1) 18 (0.4) 1c(0)
Midlands Gokwe north 1082 4583 4069 (88.8) 504 (11) 9 (0.2) 1d(0)
Gokwe South 1076 3555 3496 (98.3) 57 (1.6) 1 (0) 1e(0)
Totals 17,299 55,992 53,211 (95) 2500 (4.5) 268 (0.5) 13(0)
aDisabled.
bThree recently deceased, three blind.
cUnable to follow instructions.
dTwo blind, one unable to examine due to facial burns, one reason not given.
eRecent reaction to eye medication prevented examination.
Table 3. Examination results, Global Trachoma Mapping Project, Zimbabwe, 2014–2015.
Province District
Age (years)
1–9 10–14 15 years or greater
n TFa TIb Trichiasis n TF TI Trichiasis n TF TI Trichiasis Total
Manicaland Chipinge 1330 64 3 0 553 33 1 0 1852 53 5 6 3735
Mashonaland Central Centenary 799 229 22 0 263 17 9 1 1644 6 11 16 2706
Mbire 710 65 57 0 210 2 5 0 1829 5 12 41 2749
Rushinga 889 99 13 0 328 16 0 0 1586 13 0 10 2803
Mashonaland East Mudzi 1144 92 0 0 505 17 1 0 1677 57 7 10 3326
Mutoko 1068 83 9 0 471 32 3 0 1838 32 20 3 3377
Uzumba Maramba Pfungwe 1007 73 0 0 455 27 1 0 1793 49 7 14 3255
Mashonaland West Hurungwe 1023 27 2 0 411 6 0 0 1873 10 0 3 3307
Kariba 1096 68 2 0 403 7 0 0 1786 3 0 7 3285
Masvingo Chivi 1169 15 13 0 167 1 1 0 1256 1 0 3 2592
Midlands Gokwe north 1292 101 0 0 598 20 0 1 2179 23 5 22 4069
Gokwe South 1193 206 15 0 455 12 3 0 1848 11 2 21 3496
Matabeleland North Binga 1156 130 14 0 7 2 0 1 1765 6 2 58 2928
Hwange 1634 45 4 0 194 3 0 0 2327 1 0 7 4155
Lupane 1546 186 13 0 134 8 1 0 2146 71 36 15 3826
Matabeleland South Mangwe 1140 43 10 0 342 22 5 0 2120 14 5 63 3602
Totals 18,196 1526 177 0 5496 225 30 3 29,519 355 112 299 53,211
aTF, Trachomatous inflammation–follicular.
bTI, Trachomatous inflammation–intense.
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TF risk factors
Independent predictors of TF were identified on multi-
variable analysis. The full univariable results are shown in
Table 7. In themultivariablemodel (Table 8), children aged
1–5 years had odds of having TF 1.7 times those of children
aged 6–9 years (95%CI 1.49–1.99). In addition, children
who lived in households with a total of four or more
children had odds of TF 1.7 times those of children living
in a household with fewer children (95%CI 1.27–2.15).
Children living in households in which adults practised
Figure 1. Estimated prevalence of trachomatous inflammation–follicular (TF) among children aged 1–9 years, by district, Global
Trachoma Mapping Project, Zimbabwe, 2014–2015.
Table 4. Estimated population-level prevalence of trachomatous inflammation–follicular (TF) in children aged 1–9 years by district,
Global Trachoma Mapping Project, Zimbabwe, 2014–2015.
Province District TF Unadja TF Adjb 95% CIc
Manicaland Chipinge 4.8 4.3 [3.1–5.5]
Mashonaland Central Centenary 28.7 27.8 [21.6–35.5]
Mbire 9.2 7.8 [5.3–11]
Rushinga 11.1 9.4 [7.1–11.4]
Mashonaland East Mudzi 8.0 8.2 [6.5–10]
Mutoko 7.8 6.7 [4.4–9.7]
Uzumba Maramba Pfungwe 7.2 6.9 [5.0–8.8]
Mashonaland West Hurungwe 2.6 2.4 [1.2–4.1]
Kariba 6.2 5.5 [3.9–7.5]
Masvingo Chivi 1.3 1.5 [0.7–2.3]
Midlands Gokwe north 7.8 7.5 [5.1–10.1]
Gokwe South 17.3 16.5 [13.0–20.1]
Matabeleland North Binga 11.2 9.6 [6.3–13.8]
Hwange 2.8 2.2 [1.3–3.1]
Lupane 12.0 11.9 [8.0–15.2]
Matabeleland South Mangwe 3.8 3.2 [2.0–4.3]
aUnadjusted (crude) prevalence estimate.
bAdjusted for age in 1-year age groups using the latest available census data; Districts with a TF prevalence where mass distribution of azithromycin is
recommended are highlighted in bold.
c95% confidence interval estimated by bootstrapping the adjusted cluster-level estimates to account for the clustered design of the sampling.
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open defecation were more likely to have TF than those
who did not (OR = 1.9, 95%CI 1.65–2.28).
Living in areas where annual rainfall was at least
600 mm was associated with an increased odds of
TF (OR = 2.8, 95%CI 2.15–3.7). This effect was not
altered by the inclusion of altitude in the model.
Children living in households in which the
maximum annual outside temperature exceeded 35°
C had lower odds of trachoma than children who
lived in cooler areas. (OR = 0.3, 95%CI 0.21–0.39).
Annual mean temperature was not included in the
final model due to co-linearity with the maximum
annual temperature. Living in a household at an
altitude of more than 750 m above sea level was
Table 5. Recommendations for implementation of components of the SAFE strategy based on prevalence of trachomatous–
inflammation follicular (TF) and trichiasis, Zimbabwe, 2014–2015.
Prevalence Names of districts (n) Recommendationa
TF prevalence in 1–9 years (%)
< 5% Chipinge, Chivi, Mangwe, Hurungwe, Hwange
(n = 5)
No A, F, E needed for elimination of trachoma as a public health
problem
≥ 5% and < 10% Mudzi, Mbire, Kariba, Gokwe North, Mutoko, UMP,
Rushinga, Binga (n = 8)
Targeted A as appropriate to program needs (e.g., 1 round of MDA);
Conduct F,E
≥ 10% and < 30% Centenary, Lupane, Gokwe South (n = 3) Implementation at district; 3 rounds of A (MDA) plus implementation of
F and E, then re-survey
Trichiasis prevalence in
those aged 15 years or
greater (%)
< 0.2 Chivi, Kariba, Hwange, Mutoko, Rushinga,
Hurungwe (n = 6)
A public health approach to delivery of trichiasis surgery not necessary
for elimination of trachoma as a public health problem
≥ 0.2 Mudzi, Chipinge, UMP, Lupane, Gokwe South,
Centenary, Gokwe North, Mangwe, Mbire
and Binga (n = 10)
Scaling up of efforts to train trichiasis surgeons and implementation of
community-based case detection and management
aS, Trichiasis Surgery; A, Antibiotics; F, Facial cleanliness; E, Environmental improvement.
Figure 2. Adjusted prevalence of trichiasis in adults aged 15 years or greater, by district, Global Trachoma Mapping Project,
Zimbabwe, 2014–2015.
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Table 6. Estimated population-level prevalence of trichiasis and estimated trichiasis surgery backlogs by district, Global Trachoma
Mapping Project, Zimbabwe, 2014–2015.
Province District
Estimated population ≥15
yearsa
Trichiasis unadjb
(%)
Trichiasis adjc
(%) 95% CId
Estimated trichiasis
casese
Manicaland Chipinge 153,948 0.32 0.32 [0–0.6] 493
Mashonaland Central Centenary 63,256 0.97 0.53 [0.3–0.8] 335
Mbire 42,438 2.24 1.36 [0.8–1.9] 577
Rushinga 38,142 0.63 0.12 [0–0.2] 46
Mashonaland East Mudzi 68,645 0.6 0.23 [0–0.4] 158
Mutoko 75,278 0.16 0.12 [0–0.3] 90
Uzumba Maramba
Pfungwe
58,012 0.78 0.34 [0.1–0.6] 197
Mashonaland West Hurungwe 169,586 0.16 0.05 [0–0.1] 85
Kariba 21,312 0.39 0.13 [0–0.3] 28
Masvingo Chivi 85,540 0.24 0.16 [0–0.4] 137
Midlands Gokwe north 123,818 1.01 0.69 [0.4–1] 854
Gokwe South 157,627 1.14 0.42 [0.2–0.6] 662
Matabeleland North Binga 71,654 3.29 1.81 [1.2–2.6] 1297
Hwange 32,285 0.3 0.12 [0–0.2] 39
Lupane 51,598 0.7 0.35 [0.1–0.6] 181
Matabeleland South Mangwe 34,112 2.97 0.96 [0.6–1.3] 327
Total 1,247,251 - - - 5506
aPopulation Census 2012, Zimbabwe National Statistics Agency.
bUnadjusted (crude) prevalence estimate.
cAdjusted for sex and age in 5-year age groups using the latest available census data.
d95% confidence interval estimated by bootstrapping the adjusted cluster-level estimates to account for the clustered design of the sampling.
eEstimated by applying the adjusted trichiasis prevalence to the estimated rural population aged 15 years or greater in each district.
Table 7. Multilevel univariable associations with trachomatous inflammation–follicular (TF) in children aged 1–9 years, Global
Trachoma Mapping Project, Zimbabwe, 2014–2015.
Variable n TF% Odds Ratio 95% CI p-valuea
Individual
Sex Male 9231 8.6 1 –
Female 8965 8.2 0.97 0.87–1.08 0.5936
Age 1–5 11,302 9.6 1.54 1.36–1.73 <0.0001
6–9 6894 6.5 1 –
Household
Number of household inhabitants 1–5 13,412 8.4 1
≥6 4784 8.4 1.0 0.82–1.22 0.938
Number of children in household 1–3 16,002 8.1 1
≥4 2194 10.5 1.42 1.14–1.77 0.0016
Surface water drinking source Yes 2095 8.1 0.97 0.79–1.20 0.8193
No 16,101 8.4 1
Time to drinking water source <30 minutes 9229 7.6 1
≥30 minutes 8967 9.2 1.30 1.12–1.53 0.0008
Surface water washing source Yes 2444 7.6 0.88 0.70–1.12 0.3134
No 15,752 8.5 1
Time to washing water source All washing done at source 194 2.1 0.19 0.06–0.62 0.0405
<30 minutes 9126 7.8 1 –
≥30 minutes 8876 9.2 1.27 1.09–1.49
Household open defecation Yes 9413 10.3 1.94 1.66–2.28 <0.0001
No 8783 6.4 1
Household unimproved latrine Yes 10,999 10.1 2.19 1.85–2.59 <0.0001
No 7197 5.8 1
Household unimproved washing source Yes 7387 9.9 1.51 1.29–1.77 <0.0001
No 10,809 7.4 1
Cluster-level geoclimateb
Altitude <750 m 6258 9.9 1
≥750 m 11,925 7.6 0.70 0.59–0.82 <0.0001
Annual rainfall <600 mm 2797 4 1
≥600 mm 15,399 9.2 3.11 2.37–4.08 <0.0001
Annual mean temperature <23°C 15,033 7.8 1
≥23°C 3163 11.3 1.67 1.38–2.02 <0.0001
Annual maximum temperature <35°C 16,353 8.8 1
≥35°C 1843 4.8 0.45 0.33–0.61 <0.0001
aWald’s test.
bEstimated from the mean of household GPS coordinates at cluster-level, with climate variables extracted from Bioclim rasters (worldclim.org) at 2.5 arc-
minutes (~5km) resolution.
188 I. PHIRI ET AL.
associated with a decreased odds of TF (OR = 0.6,
95%CI 0.52–0.73) (Table 8).
Discussion
We have estimated the prevalence of TF and trichiasis
in selected areas of Zimbabwe. Making data available
on the epidemiology of trachoma at district level is the
first critical step towards planning for the implementa-
tion of the SAFE strategy. Based on our results, 11
districts (69% of those districts surveyed) were con-
firmed to have active trachoma as a public health pro-
blem according to WHO guidelines, with prevalence of
TF >5% in children aged 1–9 years (Table 3). Of 16
districts mapped, 3 (19%) had TF prevalence >10% and,
according to WHO recommendations require imple-
mentation of the A, F and E components of SAFE for
at least 3 years before re-survey. This is to say that these
districts need to start MDA with azithromycin as soon
as possible.
We found that TF was less likely to be found at higher
altitudes, consistent with a recent systematic review of
trachoma risk factors.26 In addition, the decreasing risk
of TF with increasing maximum annual temperatures has
been reported before,27 thought to be associated with
decreased eye-seeking fly activity at higher temperatures.28
However, decreasing fly activity at lower temperatures
has also been used to explain the converse relationship.26
The associations with TF found in this analysis may aid
program managers to target perceived higher risk areas in
Zimbabwe, although caution may be needed in that cli-
mate-related risk factorsmay associate with trachoma only
in specific geographic locales.
These data show that there is a significant trichiasis
surgery backlog that needs to be addressed, with the
highest numbers of surgeries needed in Binga (1297),
Gokwe North (854) and Gokwe South (662) districts
(Table 6). These results confirm previous observations
by ophthalmologists regarding the burden of trichiasis in
Gokwe, in which a visiting cataract surgery outreach
team was overwhelmed in 2015 by the number of indi-
viduals found to have trichiasis, and ended up
performing more trichiasis than cataract surgeries. In
districts with adjusted trichiasis prevalence ≥0.2% in
adults, significant expansion of existing trichiasis surgi-
cal services is needed. In keeping with the known limita-
tions of carrying out household surveys during the day,
of those aged 15 years and greater, 62.0% of those exam-
ined were female. It has yet to be established whether
those males who are missing from the surveys are repre-
sentative of those who were included. This is a potential
limitation, particularly when extrapolating survey results
to population-level trichiasis estimates, and the signifi-
cance of this may need to be established with further
research. Further limitations of our work include the risk
of multiple comparisons inflating the alpha error in the
multivariable analysis, and the difficulty in ensuring
consistent clinical grading over time, even with rigorous
initial training. Although some believe that photography
might have allowed more consistent grading across gra-
ders and time, as well as facilitating a process of auditing,
there are inherent practical difficulties in reliably captur-
ing large numbers of images from children who may not
be enthusiastic about being examined,29 in transmitting
those images elsewhere using low bandwidth internet
connections, and in having the pictures reviewed by
suitably qualified graders.
Table 5 shows recommended intervention strategies in
districts surveyed according to the population-level preva-
lence estimates of TF and trichiasis. Based on this analysis,
significant efforts will be needed in Zimbabwe to imple-
ment the SAFE strategy in order to achieve elimination of
trachoma as a public health problem by the year 2020.
Zimbabwe, by mapping trachoma in 16 districts to
date, has made a much needed start towards gener-
ating the evidence base for planning a national tra-
choma program. We readily acknowledge, however,
that our findings are only applicable to the districts
studied here, and should not be interpreted as being
representative of the country as a whole. An impor-
tant corollary of this is that areas adjacent to the
high-prevalence districts found in these surveys
(Figure 1) should now be considered suspected ende-
mic. Further efforts to more completely delineate the
Table 8. Independent predictors of trachomatous inflammation–follicular (TF) in children aged 1–9 years,
Global Trachoma Mapping Project, Zimbabwe, 2014–2015.
Variable Odds Ratio p-valuea
Age 1–5 years 1.7 <0.0001
≥4 children aged 1–9 years living in the household 1.7 0.014
Household use of open defecation 1.9 0.0002
Altitude ≥750 metres 0.6 <0.0001
Annual rainfall ≥600 mm 2.8 <0.0001
Annual maximum temperature ≥35°C 0.3 <00001
aLikelihood ratio test of inclusion/exclusion of variable in final model.
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endemic foci, and to put in place interventions where
they are required, should now follow.
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